Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Risk Reduction: early-phase trial registry
2 of 14 indexed Risk Reduction trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,230 of 28,707 conditions by registered trial count.
14 US clinical trials · 2 currently recruiting · #1,230 of 28,707 conditions by registered trial count
Risk Reduction: 14 US clinical trials tracked, 2 recruiting.
Risk Reduction is the subject of 14 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Florida State University, running 2 of these trials.
Enrollment posture brief
Registry condition risk-reduction
OPEN 2 | RECR 14% | LATE 1 | EARLY 2 | RANK #1230 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adverse Drug Events (14% recruiting · 7 trials)
Risk Reduction lists 2 open slots (14% of 14 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Risk Reduction on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Risk Reduction is recruiting below its size-band peers.
2 of 14 indexed trials (14.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Risk Reduction trials is spread across many organizations.
Florida State University accounts for 2 of 14 trials (14.3%). 12 distinct sponsors appear on at least one study for this condition label.
-
Typical Risk Reduction enrolment sits around 148 participants.
Median target enrolment is 148 among the 14 trials that report a genuine target (sentinel values excluded). 4 of those (28.6%) plan for fewer than 100 participants.
-
Risk Reduction research is mostly interventional.
13 interventional and 1 observational studies make up this index (92.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
14 total, page 1 of 1
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
San Raffaele University
NCT05732623
Blood Donor CVD 5000
University of Maryland, Baltimore
NCT03971669
Tennessee Youth Prepared for Success
Centerstone Research Institute
NCT06001892
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens
University of Kansas Medical Center
NCT04821141
Efficacy of Communication Modalities for Promoting Flu Shots
Geisinger Clinic
NCT05509270
Building Stronger Allies
Florida State University
NCT03571750
Prevention and Risk: Treatment With a New Emphasis on Relationships
Hunter College of City University of New York
NCT03396367
Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru
Florida International University
NCT05873855
Nature and Health: How Does Lifestyle and Environment Affect Health and Wellness
Stanford University
NCT06001697
Electronic Confirmed Versus Conventional Consenting Process: A Randomized Controlled Trial
The University of Texas Medical Branch, Galveston
NCT03510260
Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine
University of Maryland, Baltimore
NCT03981952
Rural Chronic Disease Risk Reduction
Florida State University
NCT05611580
PrEP Point-of-Care Brief-Intervention for Adherence Among Young Men Who Have Sex With Men
University of California, San Francisco
NCT05353283
Monitoring Environmental Exposures and Behavioral Change
University of Utah
NCT05338242
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Risk Reduction records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Risk Reduction trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Risk Reduction page
14 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Risk Reduction trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Florida State University sponsors the most Risk Reduction trials on record, review their full trial history before evaluating a specific study. See Florida State University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Risk Reduction condition card totals 14 registered trials; most-linked intervention Real-Time Exposure Feedback; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.